Close your eyes. Think of 1.6 million people. It’s hard, right? 1.6 million would fill every seat in approximately twenty-five pro football stadiums. An average city bus would have to make 27,000 trips to transport them all. And that’s how many people are currently living with or in remission from…

By E. Anders Kolb, MD | August 30, 2023 Dear Friends, I’m just over 100 days into my new role as President & CEO of The Leukemia & Lymphoma Society (LLS) and I want to take this moment to say how grateful and proud I am to work alongside all…

By Jan White, LLS Community Member and Advocate | August 04, 2023 After staring down Stage IV non-Hodgkin lymphoma in 2016, I AM HERE, and I am grateful beyond measure. However, I am learning that the treatments that saved my life came at a high cost, and that in its…

By Gwen Nichols, MD, Chief Medical Officer, The Leukemia & Lymphoma Society (LLS) | July 27, 2023 When I meet blood cancer survivors and their families, they often share their personal stories with me. Sometimes they talk about the relief of finding a treatment that finally drove their cancer into…

By E. Anders Kolb, MD | June 30, 2023 Throughout June, in commemoration of #NationalCancerSurvivorMonth, we at LLS have been highlighting the resilience and achievements of blood cancer survivors. …

By Louis J. DeGennaro, Ph.D. | June 29, 2023 Dear Friends, On July 1, I will retire after eighteen years at The Leukemia & Lymphoma Society (LLS). As I reflect on my time with the organization it’s clear that I spent these last eighteen years in the very best of…

Clinical trials are crucial for advancing cancer care. For individual patients, access to trials can be lifesaving. For researchers and doctors, trials help identify better treatments and cures. But historically, many groups of people face barriers to enrolling in clinical trials. …

For the first time in four years, blood cancer advocates convened in Washington, D.C. this spring. Together, they shared a single, critical purpose: to fight for better healthcare for cancer patients. Nearly 100 volunteers — including patients, survivors, and caregivers — urged members of Congress to champion two key pieces…

LLS continues to sustain bold progress, maintaining Cause Reports highest score and earned an esteemed “Superior” rating in its new, independent analysis of eight of the largest chronic disease organizations, recognized notably for its mission-driven “innovative programs” and “well-documented impact.” …